Disputable and unsolved aspects of mass screening
Krivoruchko, Z.A.; Rafaliuk, N.I.; Shuster, L.A.
Sovetskoe Zdravookhranenie 8: 48-51
1991
ISSN/ISBN: 0038-5239 PMID: 1962240 Document Number: 371397
A critical review of some aspects of follow-up examinations and regular check-ups is provided. A criterion of medical and economic advisability of these examinations is suggested which would permit one to substantiate their regional variations and increase their effectiveness.
Document emailed within 1 workday
Related Documents
Tsimmerman, I.S. 2004: Functional, non-ulcerative dyspepsia: current views, disputable and unsolved problems Klinicheskaia Meditsina 82(5): 16-22Abrahám, E.; Dinya, E. 1999: Current aspects of mass screening of the population for lung diseases Orvosi Hetilap 140(27): 1552
Anton'ev, A.A.; Pankova, I.V. 1975: Classification and certain other disputable aspects of allergy and dermatology Sovetskaia Meditsina 3: 109-113
Pimanov, S.I.; Makarenko, E.V. 2005: Disputable aspects of acid-suppressive therapy Klinicheskaia Meditsina 83(9): 66-69
Sawada, T.; Shikata, T.; Matsumura, T.; Kawakatsu, H.; Sugimoto, T. 1994: Analysis of 598 cases of neuroblastoma (NB) detected by screening and changes in the age distribution and incidence of NB patients after mass screening in infants in Japan. NB Screening Study Group Progress in Clinical and Biological Research 385: 371-375
Altarac, S. 2013: Individualized "opportunistic" screening for prostate cancer instead of mass population screening Lijecnicki Vjesnik 135(1-2): 51-52
Komeda, Y.; Suzuki, R.; Maeda, Y.; Okabe, S.; Kawamura, J.; Hioki, T.; Ohawa, M. 1994: Mass screening for prostate cancer at a local town--five-year results and screening system Hinyokika Kiyo. Acta Urologica Japonica 40(4): 315-318
Trehu, E.G.; Cooper, J.N. 1992: Cost of screening for colorectal cancer: results of a community mass screening program and review of the literature Southern Medical Journal 85(3): 248-254
Durand-Zaleski, I.; Bastuji-Garin, S. 2000: Evaluation of diagnostic or screening procedures. Validity of tests, sensitivity, specificity, predictive values. Definition and indications for mass screening La Revue du Praticien 50(10): 1155-1158
Hiyama, E. 2008: Neuroblastoma screening in Japan: population-based cohort study and future aspects of screening Annals of the Academy of Medicine Singapore 37(12 Suppl): 88
Akamatsu, N.; Ide, M.; Ueda, Y.; Kondo, Y.; Nakamura, S.; Mori, T.; Ogimoto, I.; Yoshimura, T. 1986: A population survey on mass screening program for gastric cancer part 1. population characteristics related to examination rates for screening program Journal of UOEH 8(2): 177-184
Ito, K.; Yamamoto, T.; Kubota, Y.; Yamanaka, H. 2000: Mass screening for prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 365-368
Grabowski, M.; Golański, J. 1981: Role of mass screening in medicine Wiadomosci Lekarskie 34(10): 867-870
Cottu, P.-H.; Cuvier, C.; Perret, F.; Gorins, A.é; Espié, M. 2003: Mass screening for breast cancer Presse Medicale 32(3): 120-124
Kronborg, O. 1984: Mass screening for colorectal cancer Scandinavian Journal of Gastroenterology 19(1): 1-5
Kitagawa, T. 1979: Mass screening of diabetes mellitus Nihon Rinsho. Japanese Journal of Clinical Medicine Suppl: 1789-1790
Timonen, S. 1971: Gynaecological mass screening in Finland Minerva Ginecologica 23(1): 7-11
Johansen, K.; Asdahl, T. 1979: Mass screening and preventive medicine Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 99(29): 1440-1441
1980: Mass screening and health controls Nordisk Medicin 95(4): 113-115
Fujimoto, I. 1984: Mass screening program for cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(3 Pt 2): 727-732